The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179: 3391-3395.
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xia, Y.
Right arrow Articles by Kellems, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xia, Y.
Right arrow Articles by Kellems, R. E.

Angiotensin Receptors, Autoimmunity, and Preeclampsia1

Yang Xia2,*, Cissy Chenyi Zhou*, Susan M. Ramin{dagger} and Rodney E. Kellems*

* Department of Biochemistry and Molecular Biology and {dagger} Department of Obstetrics Gynecology and Reproductive Sciences, University of Texas Medical School, Houston, TX 77030

Preeclampsia is a pregnancy-induced hypertensive disorder that causes substantial maternal and fetal morbidity and mortality. Despite being a leading cause of maternal death and a major contributor to maternal and perinatal morbidity, the mechanisms responsible for the pathogenesis of preeclampsia are poorly understood. Recent studies indicate that women with preeclampsia have autoantibodies that activate the angiotensin receptor, AT1, and that autoantibody-mediated receptor activation contributes to pathophysiology associated with preeclampsia. The research reviewed here raises the intriguing possibility that preeclampsia may be a pregnancy-induced autoimmune disease.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants HL076558 (to Y.X) and HD34130 (to R.E.K) and grants from the March of Dimes Foundation (6-FY06-323) and the Texas Higher Education Coordinating Board (to R.E.K.).

2 Address correspondence and reprint requests to Dr. Yang Xia, Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, Medical School, 6431 Fannin Street, Houston, TX 77030. E-mail address: yang.xia{at}uth.tmc.edu

3 Abbreviations used in this paper: AT1-AA, AT1 receptor agonistic antibody; Ang II, angiotensin II; GPCR, G protein-coupled receptor; PAI-1, plasminogen activator inhibitor-1; sFlt-1, soluble fms-like tyrosine kinase-1; RUPP, reduced uterine perfusion pressure.




This article has been cited by other articles:


Home page
HypertensionHome page
C. C. Zhou, S. Ahmad, T. Mi, S. Abbasi, L. Xia, M.-C. Day, S. M. Ramin, A. Ahmed, R. E. Kellems, and Y. Xia
Autoantibody From Women With Preeclampsia Induces Soluble Fms-Like Tyrosine Kinase-1 Production via Angiotensin Type 1 Receptor and Calcineurin/Nuclear Factor of Activated T-Cells Signaling
Hypertension, April 1, 2008; 51(4): 1010 - 1019.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.